key: cord-0806980-38uedct1
authors: Dutheil, Frédéric; Baker, Julien S; Navel, Valentin
title: The SARS-Cov-2 pandemic: a good time for stem cell transplantation?
date: 2020-06-16
journal: Biol Blood Marrow Transplant
DOI: 10.1016/j.bbmt.2020.06.009
sha: 267379a4dda9c169bd58919f02f7572a545491c1
doc_id: 806980
cord_uid: 38uedct1

nan

To the Editor: We read with interest the article by Arcuri et al. highlighting the importance of hematopoietic stem cell transplantation with specific conditioning regimens for aplastic anemia. 1 Allogenic hematopoietic stem cell transplantation (AHSCT) requires 4 to 6 weeks of hospitalization in the aim to prevent infectious complications. AHSCT has become a common practice in hematology centerswith for example around 15 000 allografts per year in Europe. 2 Visiting an allograft patient in a cleanroom obeys to strict hygienic measures such as washing the hands with an alcohol-based hand rub, maintaining social distancing, wearing a mask, or limiting visits to one a day. 3 Children are not allowed to visit. Since the end of 2019, a new highly contagious infectious diseasesevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)appeared in Wuhan, Hubei, China. 4 The local epidemic became in less than 3 months a global pandemic that forced worldwide governments to declare quarantine status and massive containment to limit the spreading of the disease. Currently, more than half the global population are in containment (more than 4 billion people). Because of their immunosuppressed status, all hematologic patients fear severe SARS-CoV-2 infection and death such as other opportunist infections. 5 Infections are the most common and significant cause of mortality after AHSCT. 6 However, the level of safety and protection against infectious diseases in transplant units is one of the highest known. 7 Usually, leaving a cleanroom after an AHSCT is a difficult time for patients because they were protected during several weeks with regular visit from nurses in a safe environment, and returning home to "normal life" is stressful. 8 In the context of the SARS-CoV-2 pandemic, returning home might have been even more stressful because patients will swap from a hospital-safecontainment in favor of several months of at-home SARS-CoV-2 containment. The stress will probably be long-term based on the 2003 SARS pandemic. 9 During the SARS-CoV-2 pandemic, the guidelines from the European Society for Blood and Marrow Transplantation preconized to defer non-urgent transplants as much as possible, considering a possible increased risk of infections, travel restrictions, and logistical reasons. 10 For those that cannot be deferred, patients must have a SARS-CoV-2 negative test to access the allograft process without visitors in transplants units. Even if it is recommended to delay non-urgent transplants for infectious reasons, the evolution of the SARS-CoV-2 pandemic and its possible consequences on the relapse of initial hematological disease are unknown. Considering that patients in need for a AHSCT process have to be contained during at least four weeks such as the global population, 11 we might wonder whether the SARS-CoV-2 pandemic could be a good time to receive allogenic hematopoietic stem cell transplantation.

A case series of post-transplant cyclophosphamide in unrelated donor hematopoietic transplantation for aplastic anemia

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

The importance of cleanrooms for the treatment of haematooncological patients

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

An overview of infectious complications after allogeneic hematopoietic stem cell transplantation

Isolation in the allogeneic transplant environment: how protective is it?

What does isolation mean in home healthcare? Home Healthc Nurse

Stress and psychological distress among SARS survivors 1 year after the outbreak

EBMT COVID-19 guidelines v.4.3 (2020-03-23).pdf. Accessed

The psychological impact of quarantine and how to reduce it: rapid review of the evidence